NEW FILINGS<\/p>\n
TERMS ADDED<\/p>\n
Company: Alector, Inc.
\nSymbol: ALEC
\nDescription: They are a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration.
\nShares: 9.25 million
\nPrice Range: $18.00-$20.00
\nTrade Date: 2\/7
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays
\nTerms Added: 1-29-19<\/p>\n
Company: Harpoon Therapeutics, Inc.
\nSymbol: HARP
\nDescription: They are a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body\u2019s immune system to treat patients suffering from cancer and other diseases.
\nShares: 5.4 million
\nPrice Range: $13.00-$15.00
\nTrade Date: 2\/8
\nUnderwriter(s): Citigroup, SVB Leerink
\nCo-Manager(s): Canaccord Genuity, Wedbush PacGrow
\nTerms Added: 1-29-19<\/p>\n
Company: Virgin Trains USA Inc.
\nSymbol: VTUS
\nDescription: They own and operate an express passenger rail system connecting major population centers in Florida, with plans to expand operations further in Florida, Las Vegas and elsewhere in North America.
\nShares: 28.3 million
\nPrice Range: $17.00-$19.00
\nTrade Date: 2\/13
\nUnderwriter(s): Barclays, J.P. Morgan, Morgan Stanley, BofA Merrill Lynch, Allen & Co.
\nCo-Manager(s): JMP Securities, Raymond James, Stephens Inc.
\nTerms Added: 1-30-19<\/p>\n
Company: Anchiano Therapeutics Ltd.
\nSymbol: ANCN
\nDescription: They are a clinical-stage biotechnology company committed to engineering a targeted gene therapy to improve the standard treatment for early-stage bladder cancer, which is one of the most prevalent forms of cancer. Their ordinary shares are listed on the Tel Aviv Stock Exchange Ltd., or the TASE, under the symbol “ANCN”.
\nShares: 2.4 million ADSs
\nPrice Range: $14.55-$14.55
\nTrade Date: 2\/12
\nUnderwriter(s): Oppenheimer & Co.
\nCo-Manager(s): Ladenburg Thalmann
\nTerms Added: 1-31-19<\/p>\n","protected":false},"excerpt":{"rendered":"
NEW FILINGS TERMS ADDED Company: Alector, Inc. Symbol: ALEC Description: They are a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Shares: 9.25 million Price Range: $18.00-$20.00 Trade Date: 2\/7 Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays Terms Added: 1-29-19 Company: Harpoon Therapeutics, Inc. Symbol: HARP Description:[…]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-6838","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/6838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=6838"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/6838\/revisions"}],"predecessor-version":[{"id":6839,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/6838\/revisions\/6839"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=6838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=6838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=6838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}